Showing results (121-130 of 427) with videos related to
Sort By:
Pageof 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2012
A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumorsKomal Jhaveri, Kathy Miller, Lee Rosen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancerJ Crown, A Kritz, L Vahdat, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2007
BRCA mutations in women with ductal carcinoma in situKaren Lisa Smith, Muriel Adank, Noah Kauff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Cardiac dysfunction in the trastuzumab clinical trials experienceAndrew Seidman, Clifford Hudis, Mary Kathryn Pierri, et al.Nano Letters|October 13, 2020
Controlled Fabrication of DNA Molecular Templates for In Situ Formation and Measurement of Ultrathin Metal NanostructuresJorge L Barreda, Longqian Hu, Liuqi Yu, et al.Annals of the New York Academy of Sciences|November 30, 1993
High-intensity chemotherapy with hematopoietic support in breast cancerJ Crown, L Vahdat, D Fennelly, et al.Journal of Clinical Pathology|January 6, 2006
Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumoursC Van Poznak, S S Cross, M Saggese, et al.Cancer|September 3, 2011
Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancerAna P Kiess, Heather L McArthur, Kathleen Mahoney, et al.Cancer|March 26, 2003
Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutationsNoah D Kauff, Edi Brogi, Lauren Scheuer, et al.Breast Cancer Research and Treatment|April 13, 2013
A multicenter trial evaluating retaspimycin HCL (IPI-504) plus trastuzumab in patients with advanced or metastatic HER2-positive breast cancerShanu Modi, Cristina Saura, Charles Henderson, et al.Pageof 43